Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds
Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval
Liver Transplants Extend Survival In Early-Stage Cancer
Trimodality Therapy Improves Survival In Early Disease
NCI Encourages IP Chemo For Stage III Ovarian Cancer
Study Finds No Evidence That Statins Cut Cancer Risk
Chest X-Ray Produces Many False-Positive Results
NMP22 Assay More Effective Than Conventional Lab Test
Chemotherapy After Surgery Extends Survival By 32%
Some Tumors Show Partial Response To Drug Combo
Recombinant TSH Avoids Need To Stop Replacement Therapy
Partial Responses To Zactima In Thyroid Cancer Trial
NCI-Approved Clinical Trials
Trending Stories
- Christine Lovly to lead City of Hope’s new national thoracic oncology program
- FDA to remove black box warnings on hormone therapy for menopause
Trump-era “gold standard science” is not to be confused with gold standard of scientific evidence - Rick Pazdur’s CDER appointment comes at exactly the right moment for FDA
- Smoldering multiple myeloma: Rethinking the waiting game
- Richard Pazdur, a respected insider with a plan to reengineer FDA, steps in as CDER director
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case









